Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Error-pooling-based statistical methods for identifying novel temporal replication profiles of human chromosomes observed by DNA tiling arrays.
PMID 17430969 · PMC1888820 · Nucleic acids research · 2007 · 8 claims · 4 setups
Developed an LPE-based error-pooling and weighted ANOVA modeling approach for statistical analysis of high-density tiling array data
-
Full-text index only
SNP haplotype tagging from DNA pools of two individuals.
PMID 12709267 · PMC156884 · BMC bioinformatics · 2003 · 8 claims · 3 setups
An algorithm can reconstruct haplotypes from pools of two individuals' DNA under very general conditions, without requiring Hardy-Weinberg equilibrium.
-
Full-text index only
Highly cost-efficient genome-wide association studies using DNA pools and dense SNP arrays.
PMID 18276640 · PMC2346606 · Nucleic acids research · 2008 · 8 claims · 5 setups
Illumina HumanHap300 arrays are substantially more efficient than Affymetrix Genechip HindIII arrays for DNA-pooling based GWAS
-
Full-text index only
Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease.
PMID 19746990 · PMC2784247 · Journal of proteome research · 2009 · 8 claims · 5 setups
A label-free XIC-based LC-MS/MS quantitation strategy, combined with an FTLD-U comparator cohort, can be used to identify AD-specific changes in the detergent-insoluble brain subproteome.
-
Full-text index only
Applicability of DNA pools on 500 K SNP microarrays for cost-effective initial screens in genomewide association studies.
PMID 17610740 · PMC1925094 · BMC genomics · 2007 · 8 claims · 5 setups
SNP-MaP can be effectively applied to the Affymetrix 500K GeneChip, providing a cost-effective, reliable and valid initial genomewide screen